Patients who were older than 18 years of age and met the criteria of sudden hearing loss without an identifiable etiology were . Learn more about our Blue Distinction Center designation . We also offer the only adult hematopoietic stem-cell transplant services in Orange County, which means that patients with leukemia, lymphoma and other cancers no longer need to travel long distances for this life-saving treatment. El Segundo, CA . Before joining the Chao Family Comprehensive Cancer Center to lead its program in hematopoietic stem cell transplantation and cellular therapy, Ciurea served for more than a decade on the faculty of the MD Anderson Cancer Centers Department of Stem Cell Transplantation and Cellular Therapy. For example, radiation or chemotherapy may be used to shrink a tumor before surgery. Division of Hematology/OncologyDepartment of MedicineUCI School of Medicine 101 The City Drive South, Building 56, ZOT 4061Orange, CA 92868 MAPBusiness office: 714-456-5153Business fax: 714-456-2242. The emphasis is on understanding the pathologic process of diseases, the resulting functional changes, their clinical manifestations and complications, as well as diagnostic methodology, standard and experimental therapeutic modalities, clinical trials and research. Frank Meyskens, MD Director Emeritus, Chao Family Comprehensive Cancer Center. We are devoted to making novel discoveries that lead to new strategies for disease treatment and prevention and to translating them into clinical trials that deliver the most effective treatments to our patients. Access MyChart Overview Education Bio Locations Medical Services Lung Cancer Services Medical Oncology Services These affiliations give our patients the expertise of a scientific community that is internationally renowned for its work in the prevention, diagnosis and treatment of cancer. I am so glad I picked the right Oncologist. The philosophy of our program emphasizes the patient as the best teacher. Incumbent will be responsible for the development and growth of UCI's early phase clinical trials portfolio for both oncology and non-oncology indications, across the UCI Chao Family Comprehensive Cancer Center's (CFCCC) Stern Center for Cancer Clinical Trials & Research (Stern Center), the UCI Center for Clinical Research (CCR), and the UCI Alpha Stem Cell Clinic (ASCC). The posted UC salary scales set the minimum pay determined by rank and/or step at appointment. Learn more about our multidisciplinary cancer teams and related services, including: Located on the UCI Medical Center campus in Orange, the UCI Health Chao Family Comprehensive Cancer Center is affiliated with the UCI School of Medicine and the university's schools of basic sciences. People diagnosed with cancer typically need a range of medical specialists, treatments and services, all of which are available at the UCI Health Chao Family Comprehensive Cancer Center, Orange County's only National Cancer Institute-designated comprehensive cancer center. She has a particular interest in benign and malignant hematology, genitourinary malignancies, and cancer prevention. Michelle Clark-Salib fought cancer and delivered a healthy son, COVID-19 vaccine and protecting your health , National Cancer Institute-designated comprehensive cancer center in Orange County, only adult hematopoietic stem-cell transplant services, Our cancer experts also are available to provide second opinions , Hematology-Oncology Services (Leukemia, Lymphoma and Myeloma), Quality OncologyPractice Initiative (QOPI) CertificationProgram, Blue Distinction Center for Complex and Rare Cancers, Learn more about our Blue Distinction Center designation , 53 National Cancer Institute (NCI)-designated comprehensive cancer centers, HIPEC, or hyperthermic intraoperative peritoneal chemotherapy, Stem cell transplant wards off aggressive lymphoma, Dedicated to cancer research & treatment (video), OCMA honors UCI Health 'Physicians of Excellence', 2022 UCI Anti-Cancer Challenge raises record $1 million for promising cancer research, UCI Health honored for surgical safety and excellence, UCI opens first natural killer cell clinical trial for recurrent glioblastoma, $8 million grant expands access to UCI stem cell clinical trials, Gastric cancer patient gets new lease on life, Riding tall a decade after prostate surgery, A novel approach to advanced stomach cancer, Take a virtual tour of the infusion center at UCI Health Cancer Center Newport , Integrate innovative research with the most advanced diagnostics, treatments, rehabilitation and, Offer one of the largest early-phase clinical trials programs in Southern California, giving our patients access to promising therapies before they are available elsewhere. 2023 The Regents of the University of California. MD , Full Professor of Medical Oncology. At any given time, UCI is participating in at least 200 clinical trials, many of them developed by CFCCC members. Our researchers are at the forefront not only in treating cancer, but also in preventing it. When expanded it provides a list of search options that will switch the search inputs to match the current selection. Cancer patients at UCI Health benefit from an individualized treatment plan tailored to their specific condition. If you are not already licensed in the state, contact the Medical Board of California online or at 1426 Howe Ave., Suite 54, Sacramento, CA 95825-3236. Meanwhile, we continue to provide full services and clinical trial options to our patients while taking exacting precautions for their safety and that of our staff. Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. Join to apply for the . Phone: (714) 456-7511 Fax: (714) 456-6025 Email: obrien@uci.edu University of California, Irvine 101 The City Drive South Building 23, Room 405 Mail Code: 2675 Orange, CA 92868 Research Interests Hematologic malignancies, both acute and chronic leukemia URL Chao Family Comprehensive Cancer Center Publications The hematology division provides diagnostic, therapeutic and consultative care to children with hematologic disorders such as hemophilia, anemia and platelet disorders. Help advance education and research in the Division of Hematology/Oncology through charitable giving. The EAB reviews the overall strategy and progress and makes specific recommendations to the CFCCC director to improve our goals under our mission. We are participating in a National Cancer Institute clinical trial to determine whether COVID-19 affects therapies in cancer patients who acquire the virus. After more than a decade of work helping patients like Allen Fremont, Dr. Sai-hong Ignatius Ou has gained FDA approval for a drug treatment that targets mutations of non-small cell lung cancers. We offer lifesaving treatment options for blood and lymph cancer patients with the launch of Orange County's first adult stem cell transplant and cellular therapy program. The University of California, Irvine, School of Medicine, Department of Medicine, Division of Hematology/Oncology is seeking a dynamic leader with strong credentials in clinical medicine and basic, translational, or clinical research for the position of Hematology/Oncology Division Chief. We are also a Blue Distinction Center for Complex and Rare Cancers. We also offer additional services, such as dietary guidance, pain management, counseling and support groups. If this collaborative, respectful, and inclusive approach speaks to you, I look forward to your selection of UCI Department of Medicine as your training program of choice. We strive to provide the best possible care, tailored for each patient's individual needs. Our medical oncologists are part of a team that treats patients affected by a wide range of cancers and blood disorders at the UCI Health Chao Family Comprehensive Cancer Center, Orange County's only National Cancer Institute-designated comprehensive cancer center. Oversees and is responsible for the adherence of the technical staff to these SOPs He completed an internal medicine residency at UPMC Pinnacle Harrisburg in Harrisburg, Pa. A disability plan is available through the Irvine House Staff Association. Our faculty members are subspecialty-trained, board-certified hematologists and oncologists who care for inpatients at UCI Medical Center and outpatients at Chao Family Comprehensive Cancer Center, which is the only National Cancer Institute-designated comprehensive cancer center in Orange County and one of only 50 in the nation. He sees patients at the UCI Health Chao Family Comprehensive Cancer Center in Orange. Appointment as Clinical Staff Investigator within the Chao Family Comprehensive Cancer Center [P30 Cancer Center Support Grant] April 2019- present (one of only two positions at UCI) 16. MyChart patient portal offers a convenient and secure way to manage your healthcare online. Clinical Professor, Division of Hematology/Oncology, Medicine School of Medicine Associate Director for Clinical Sciences, Chao Family Comprehensive Cancer Center M.D., Chicago Medical School, 1986, Medicine B.S., University of Southern California, 1981, Psychobiology Phone: (714) 456-5153 Fax: (714) 456-2242 Email: wachow@uci.edu Assistant/ Associate/ Full Professor In Residence (Hematology/Oncology) UC Irvine Irvine, CA. We work closely with you and your family to discuss potential treatment options and encourage questions. Treatments and therapies may include surgery, radiation and chemotherapy, individually or in combination, depending on your personal health and the type and stage of your cancer. Jason A. Zell, DO, MPH, MSDirector, Fellowship Program, Elizabeth Yi, MPH, MBADivision Administrator Email:elizabeth.yi@uci.edu, Elizabeth AndersonAcademic Programs AnalystEmail: elizabeth.anderson@uci.edu, Christopher G. HaymondBusiness Support Assistant AnalystEmail:chaymond@uci.edu, Elizabeth PearsonClinical Programs Assistant Analyst & Administrative Assistant to Division ChiefEmail: epearson@uci.edu, Christopher SongEducation Programs Assistant AnalystEmail:csong3@uci.edu, University of California, Irvine Irvine, CA 92697. The Division of Hematology/Oncology at the UCI School of Medicine's Department of Medicine offers a rigorous three-year accredited fellowship program that emphasizes intensive theoretical training and a broad spectrum of clinical experience with the goal of preparing highly skilled hematologists and oncologists for careers in both clinical and academic medicine. May 18-22, 2012 15. In the last decade, we have increased patient access to our more than 300 clinical trials by 90%. This button displays the currently selected search type. For graduates of medical schools outside the United States, please note that the licensure process can take six to 12 months or longer. COVID-19 vaccine and protecting your health , UCI Health Chao Family Comprehensive Cancer Center in Orange, Professor Division of Hematology/Oncology, Department of Medicine, UCI School of Medicine, Director UCI Health Hematopoietic Stem Cell Transplant and Cellular Therapy Program. Dr. Nataliya Mar is an associate professor at UC Irvine Chao Comprehensive Cancer Center, who specializes in treatment of genitourinary malignancies including prostate, bladder, kidney, testicular and penile cancers. We are engaged in basic and translational cancer research to better understand cancer and blood diseases and also to use the best, leading-edge clinical approaches for our patients. It also underscores our commitment to cancer prevention research as well as our extensive community outreach and education programs. Elizabeth Brem, MD, on Frontline Management of CLL, UCI and CSU Fullerton partner to advance cancer health disparities research with a focus on diversity and inclusion, Virus-based sensor detects bladder cancer markers in urine, 200 S. Manchester Drive, Orange, CA 92868-3217, General Medical Appointments: 714-456-8000, Biotechnology, Imaging & Drug Development, Stern Center for Cancer Clinical Trials and Research, Acknowledgement of Grant and Shared Resources, Anti-Cancer Challenge Pilot Research Projects, CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP), UCI Susan & Henry Samueli College of Health Sciences. Clinical trials often compare the most accepted cancer treatments with new treatments that our physicians and researchers hope will be more effective. Faculty members in these divisions are involved in a number of research projects. CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP) UCI School of Medicine . Our cancer specialists are leaders in Orange County and Southern California in performing HIPEC, or hyperthermic intraoperative peritoneal chemotherapy, for late-stage and recurrent colorectal, gastric, ovarian and other cancers in the abdominal area. Universitatea de Medicina si Farmacie Iasi, Fax:
At the UCI Health Chao Family Comprehensive Cancer Center, we help you fight cancer on all fronts. The multidisciplinary cancer center at UCI Medical Centeris supported by more than 200 UCI faculty members from five schools and 23 departments. Salary range: The salary range for the Assistant Professor In Residence rank position is $82,200-$107,700. Farshid Dayyani, MD, PhD . We remain committed to advancing diversity, in its broadest sense, in our programs through recruitment, training, retention and mentoring. We also are passionate about fostering these discoveries within the context of a dynamic environment that is focused on developing top-caliber physician and scientists. If you are not already licensed in the state, contact the Medical Board of California at 1426 Howe Ave., Suite 54, Sacramento, CA 95825-3236. The Division of Hematology/Oncology at the UCI School of Medicine's Department of Medicine offers a rigorous three-year accredited fellowship program that emphasizes intensive theoretical training and a broad spectrum of clinical experience with the goal of preparing highly skilled hematologists and oncologists for careers in both clinical and For more information, call us at 714-456-8000 or fill out an appointment request form . Fellows are required to undertake dedicated clinical and/or laboratory research under the supervision of a research mentor. Fellows' List of Research Publications 2010-2018 (fellows names appear in bold), Associate Program Director Lisa X. Lee, MD, Associate Program Diorectr Ann Eapen, MD, Research Rotation Director Angela Fleischman, MD, PhD, Division Chief: Edward L. Nelson, MD, FACP, Christopher SongEducation Programs Assistant AnalystPhone: 714-456-6589Fax: 714-456-2242E-mail: csong3@uci.edu, The Division of Hematology/OncologyUCI Medical Center101 The City Drive SouthBuilding 56, Room 239, ZOT 4061Orange, CA 92868, University of California, Irvine Irvine, CA 92697, Accreditation Council for Graduate Medical Education (ACGME), American Board of Internal Medicine (ABIM), Educational Commission for Foreign Medical Graduates (ECFMG), Electronic Residency Application Service (ERAS), A novel method for demonstrating cold agglutinin disease: a case report, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905110/, Secondary hemophagocytic lymphohistiocytosis in the setting of metastatic renal cell carcinoma: a case report, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333406/, PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533281/, Prostatic Lymphoma Masquerading as Urinary Retention and Hematuria With Review of Literature, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650011/, http://pancreas.imedpub.com/pancreatic-neuroendocrine-tumors-therapy.pdf, Inotuzumab ozogamicin for the treatment of patients with acute lymphocytic leukemia, https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=2737934, Treatment of pregnancy associated metastatic hormone and Her-2 receptor positive inflammatory breast cancer: A real challenge, https://doi.org/10.1016/j.ctarc.2016.09.003, https://www.sciencedirect.com/science/article/pii/S2468294216300739, Deadly Portland Cement: The Triad of Pulmonary, Dermatologic and Hematological Manifestations, https://www.sciencedirect.com/science/article/pii/S0002962916301379?via%3Dihub, BRAFV600E Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008024/, Primary Hepatic Osteosarcoma: A Rare Cause of Primary Liver Tumor, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827792/. Pediatric Hematology-Oncology (5) 41 years exp . We are physicians and scientists committed to improving the condition of patients with cancer and blood disorders through state-of-the-art clinical care, research and education. Formal teaching and attending rounds are held daily at the medical center in Orange and at the VA in Long Beach. Faculty members in these divisions provide clinical services at CHOC Childrens Hospital. Dr. Tara E Seery, MD . External Advisory Board (EAB) The EAB serves a key role in the CFCCC's planning and evaluation of its three cancer research programs, shared resources and supporting research infrastructure. Stem Cell Transplant rotations are held at the UCIMC. Contact Us Division of Hematology/Oncology Department of Medicine UCI School of Medicine 101 The City Drive South, Building 56, ZOT 4061 Orange, CA 92868 MAP Business office: 714-456-5153 Business fax: 714-456-2242 For clinical services and appointments, please call 714-456-8000 or fax to 714-456-7142. Division of Hematology/Oncology. At the UCI Chao Family Comprehensive Cancer Center, we work to prevent, manage, and cure cancer so all people live healthier, longer lives. For more information, call us at 714-456-8000 or fill out an appointment request form Individual Treatment Plans During the second and/or third year fellows develop and participate in a longitudinal research project spanning 18 months of protected time under the supervision of research mentor. The Divisions of Hematology and Oncology are committed to the delivery of exemplary clinical care, to advancing research and to training future healthcare professionals. Dr. Monica El-Masry is a hematologist and medical oncologist who practices in Porter Ranch and at the Veteran's Affairs Medical Center. For questions about the application process, go to ERAS online or call 215.966.3940. One each from columns A and B. This year, the COVID-19 pandemic has posed challenges for so many of our patients. Learn more about our research and clinical trials , Sign up for our monthly e-newsletter and get the latest health tips and stories from our Live Well blog . The fellowship program is designed to educate and support future clinical investigators who plan to dedicate their professional careers to clinical or laboratory research in hematology and oncology. UCI Health hematologic oncologists provide consultation and treatment for patients with many different types of cancer, These include including malignancies of the blood such as leukemia, lymphoma and myeloma, as well as solid tumor carcinomas such as colon, breast and prostate. The infusion center at UC Irvine Health Cancer Center Newport emphasizes tranquility and healing, along with personalized care. Participation in the review of clinical trial protocols through involvement in the institutional review board (IRB) is expected during the second and third year. . He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston. At the cancer center, you are cared for by a world-class team of cancer specialists, including medical oncologists, surgeons, radiation oncologists and pathologists, as well as highly trained nurses, rehabilitation therapists, pharmacists, social workers and dietitians. Fellowship candidates must have completed an ACGME-accredited Internal Medicine residency program. He also has served as principal investigator on multiple clinical trials, including investigator-initiated trials. Fellows participate in weekly didactic lectures as well as academic activities including journal club, M&M, quality improvement, hematology conference, and disease specific lectures. Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study Latest version (submitted February 28, 2023) on ClinicalTrials.gov A study version is represented by a row in the table. As the only National Cancer Institute-designated comprehensive cancer center in Orange Countyand the only one ranked among the nation's top 50 by U.S. News & World Report, we treat more patients with cancer and more complex cases than any other healthcare provider in our region. Candidates also must have a valid California medical license before beginning the fellowship program as required by state law. Applicants also must have: Candidates also must have a valid California medical license before beginning the fellowship program as required by state law. See Professorial Series (Adjunct, Clinical X, HS Clinical, In Residence, Ladder Rank) and Professor of Teaching Series Professor and Chair, Department of Radiation Oncology, Program Co-Leader, Biotechnology, Imaging & Drug Development, Professor, Dermatology and Biological Chemistry, Co-Chair, Protocol Review and Monitoring Committee, Associate Vice Chancellor, Clinical and Translational Science, Director, Institute for Clinical and Translational Sciences, School of Medicine Vice Dean for Clinical Science, Associate Director, Cancer Research Training & Education Coordination, Medical Director for the Stern Center for Cancer Clinical Trials & Research, Professor of Clinical Medicine, Hematology/Oncology, Director Emeritus, Chao Family Comprehensive Cancer Center, Professor of Medicine, Biological Chemistry and Public Health, School of Medicine Vice Dean for Basic Science, Professor, Chemistry and Molecular Biology and Biochemistry, Associate Vice Chancellor, Strategic Initiatives, Office of Research, Program Co-Leader, Systems, Pathways & Targets, Associate Director, Population Science & Cancer Control, Division Chief of Surgical Oncology, Department of Surgery, Co-Director of Center for Cancer Systems Biology, Senior Associate Dean & Associate Vice Chancellor for Cancer, Associate Director, Cancer Health Disparities & Community Engagement, Professor, Epidemiology, School of Public Health, Director, Genomics Research and Technology Hub (GRTH), Professor, Biomedical Engineering & Surgery, 200 S. Manchester Drive, Orange, CA 92868-3217, General Medical Appointments: 714-456-8000, Biotechnology, Imaging & Drug Development, Stern Center for Cancer Clinical Trials and Research, Acknowledgement of Grant and Shared Resources, Anti-Cancer Challenge Pilot Research Projects, CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP), UCI Susan & Henry Samueli College of Health Sciences. As a university medical center, we typically have dozens of clinical trials in progress addressing different conditions, including "refractory" cancers that do not respond to standard treatments. Dr. Sender, medical director of the oncology services team at the Chao Family Comprehensive Cancer Center, is a nationally known expert in disorders of the blood and lymphatic system.